JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Effects of lercanidipine on traumatic spinal cord injury: an experimental study

  • 0Department of Neurosurgery, Tepecik Research and Training Hospital, University of Health Sciences, İzmir-Türkiye.
Ulusal Travma Ve Acil Cerrahi Dergisi = Turkish Journal of Trauma & Emergency Surgery : Tjtes +

|

February 2, 2024

|

February 2, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Lercanidipine, a calcium channel blocker, reduced inflammatory responses in a rat spinal cord injury model. While not affecting apoptosis, it shows potential for managing inflammation after such trauma.

Area Of Science

  • Neuroscience
  • Pharmacology
  • Trauma Research

Background

  • Spinal cord injury (SCI) results in lifelong medical complications.
  • Lercanidipine, a calcium channel blocker, has anti-apoptotic, anti-inflammatory, and antioxidative properties.
  • Investigating lercanidipine's neuroprotective effects in SCI is crucial.

Purpose Of The Study

  • To evaluate the neuroprotective potential of lercanidipine in an experimental spinal cord trauma model.
  • To assess the impact of lercanidipine on inflammatory markers post-SCI.
  • To determine if lercanidipine influences apoptosis in SCI.

Main Methods

  • Wistar rats were divided into three groups: laminectomy only, laminectomy with trauma, and laminectomy with trauma plus lercanidipine treatment.
  • Lercanidipine was administered intraperitoneally for seven days.
  • Histopathological and immunohistochemical analyses, including TUNEL staining and NF-κB assessment, were performed.

Main Results

  • No significant differences in Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were observed across groups.
  • Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) levels were significantly elevated in the trauma group compared to controls.
  • Lercanidipine treatment significantly reduced NF-κB levels compared to the trauma-only group.

Conclusions

  • Lercanidipine effectively mitigates inflammatory responses in spinal cord injury.
  • The study suggests lercanidipine's anti-inflammatory action in SCI, but its role in apoptosis prevention requires further investigation.
  • This research is the first to explore lercanidipine's neuroprotective effects in a spinal cord injury model.